Hannah Williams

PR @ STiR-Communications

[Citius Pharma @CitiusPharma]

Pleased to see continued media coverage highlighting the growing clinical and commercial momentum around LYMPHIR™ from our oncology subsidiary, Citius Oncology.

Check out the coverage:

@RareDiseaseAdv - Denileukin Diftitox Before CAR-T Therapy Shows Potential in DLBCL https://t.co/3Y9L9ISgrn

@TargetedOnc - A New Era in CTCL: The Dual-Action Potential of Denileukin Diftitox https://t.co/XfQQdQdgK5

@TheCancerLetter - Positive topline results announced from phase I study of LYMPHIR + pembrolizumab in r/r gynecologic cancers https://t.co/N2SjjgfkJ0

Rare Cancer News - Immune duo safely targets hard-to-treat gynecological cancers https://t.co/6zt9bEIWE4

@CancerNetwrk - Denileukin Diftitox Combo Yields Activity in R/R Gynecologic Cancers https://t.co/9J7pQ8dbqY

$CTXR $CTOR

[Citius Pharma @CitiusPharma]

🎙️ Host Max Brennan of The BioHub podcast recently featured Citius Pharmaceuticals Chairman and CEO Leonard Mazur.

Tune in to episode 187 for a conversation on what it takes to build and scale a biotech company, from entrepreneurship and commercialization to the evolution of Citius Pharmaceuticals, today's biotech market, and lessons from decades of building healthcare companies.

https://t.co/0zj8tq8CXU $CTXR $CTOR

[CBS News @CBSNews]

A grandfather struggled with treatment for late-stage pancreatic cancer — until a clinical trial helped him beat the odds. https://t.co/3E7FHN1dXR

[Business Travel News @btnonline]

MGME Acquires Key Meetings & Events https://t.co/gnljlSL2iv

[Travel Weekly @TravelWeeklyUS]

InteleTravel's MGME acquires Key Meetings & Events agency https://t.co/eqj2nFxCMz

[RenovoRx @RenovoRx]

A recent @CBSNews feature highlights the story of a patient with late-stage #pancreaticcancer who participated in RenovoRx’s TIGeR-PaC clinical trial evaluating our TAMP™ platform, enabled by the RenovoCath® device. The story underscores the potential of this approach to deliver chemotherapy directly near the tumor site while reducing systemic side effects associated with IV chemotherapy. Read here: https://t.co/MoZiYEXZGM

#TargetedTherapy #LocallyAdvancedPancreaticCancer #LAPC

[ICRealtime @ICRealtime]

'Do the thing that moves the lever, not the things that just make you feel busy.'

Our Co-Founder Bob Odierno in @SSIMagazine Q&A. Full Q&A here: https://t.co/L7WY40FBOO

[Andy | The Secure Dad ® @thesecuredad]

Do you own your home security footage? Industry expert, Matt Sailor of IC Realtime explains why Wi-Fi cameras may not be as private as you think. Watch our full interview on The Secure Family Podcast: https://t.co/yFXS3ja31T

[RenovoRx @RenovoRx]

.@Medsider spoke with RenovoRx CEO, Shaun Bagai, about the foundation of the TAMP™ therapy platform and shares how early lessons from his career have helped shape the Company’s commercialization strategy into a well-defined market. https://t.co/S6DBN0vQto $RNXT

[RenovoRx @RenovoRx]

RenovoRx CEO Shaun Bagai talks leadership, career lessons, and MedTech insights on The Leading Difference podcast. Now available on all major podcast platforms. Listen here: https://t.co/TUEWz9DlEc $RNXT

[Barron's @barronsonline]

Verizon Offers $20 Credits After Resolving Outage Affecting Millions https://t.co/4Vd931Xt8Y

[FOX 10 Phoenix @FOX10Phoenix]

A Paradise Valley construction worker is alive after a traumatic injury at work. FOX 10's Steve Nielsen learns how a new tool officers had ready to deploy to stop the bleeding. https://t.co/6Ih02sWZdA

[Targeted Oncology @TargetedOnc]

Myron Czuczman, MD, chief medical officer at Citius Pharmaceuticals, spoke with #TargetedOncology about the mechanism of action of denileukin diftitox and the effect it can have on patients with #CTCL.👨‍🔬 https://t.co/CLIpFBVkTJ

[David Baker @MrDBake]

Paradise Valley police are using a new product to save lives
https://t.co/HYtDLKF9ri

[Hannah Williams @HWilliamsPR]

Another great local story spotlighting @RenovoRx and the use of RenovoCath at @cityofhope. Thank you to @SpecNews1SoCal for telling this important story: https://t.co/311zbQP71o

[RenovoRx @RenovoRx]

Our CEO, Shaun Bagai, joined @medtech_101 to discuss how RenovoRx is potentially changing the treatment landscape for patients with diagnosed with difficult-to-treat tumors, like pancreatic cancer, with our patented TAMP™ therapy platform, designed for targeted drug-delivery via the RenovoCath® device. https://t.co/nurrqx8S9r

[Allen Wenner, M.D. @doctorwenner]

After decades working in medicine, I’ve seen the pros and cons that come with our current system. Let’s take action to make effective change for patients & doctors: https://t.co/T6tanPNF5y

[STiR Communications @STiR_Comms]

On #WorldKindnessDay, preschoolers at @TheLearningExp put compassion into action by giving back to their community and learning what it truly means to be kind.

Thanks to @CBS58 for highlighting this heartwarming story from our franchise PR client.

https://t.co/w9YtY7nnGV

[Hannah Williams @HWilliamsPR]

Another great story on @TheLearningExp's ASL curriculum. Thanks to @IsabelaLisco & @KOLDNews for coming out! https://t.co/KFznTI8QaO

[Hannah Williams @HWilliamsPR]

@TheLearningExp is teaching babies & toddlers basics of sign language - more from @KarinaRubioTV in @azfamily: https://t.co/Kos1ujxxu6